PRESS RELEASE published on 07/16/2025 at 07:00, 1 year 2 months ago Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge Sanofi obtient la désignation 'fast track' pour le traitement innovant de l'atrophie géographique liée à la dégénérescence maculaire. Le SAR446597 vise à inhiber des voies clés du complément pour une meilleure efficacité Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track Atrophie Géographique
PRESS RELEASE published on 07/16/2025 at 07:00, 1 year 2 months ago Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Sanofi's SAR446597 receives fast track designation in the US for geographic atrophy due to age-related macular degeneration, aiming to address unmet medical needs with innovative gene therapy Gene Therapy Sanofi Fast Track Designation Geographic Atrophy SAR446597
PRESS RELEASE published on 07/15/2025 at 18:30, 1 year 2 months ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 07/15/2025 at 18:30, 1 year 2 months ago Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE published on 06/30/2025 at 21:33, 1 year 2 months ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 06/30/2025 at 21:33, 1 year 2 months ago Sanofi : Déclaration des transactions sur actions propres
BRIEF published on 06/30/2025 at 07:35, 1 year 2 months ago Sanofi Releases Q2 2025 Aide Mémoire Forward-looking Statements Investor Information Financial Modeling Aide Mémoire Sanofi Q2 2025
BRIEF published on 06/30/2025 at 07:35, 1 year 2 months ago Sanofi publie son aide-mémoire pour le deuxième trimestre 2025 Informations Pour Les Investisseurs Énoncés Prospectifs Modélisation Financière Aide-mémoire Sanofi T2 2025
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 2 months ago Press release: Availability of the Q2 2025 Aide mémoire Sanofi releases Q2 2025 Aide mémoire for financial modelling, to be published on July 31, 2025. Company details its commitment to innovation and impact in healthcare Innovation Sanofi Aide Mémoire Financial Modelling Q2 2025
BRIEF published on 06/25/2025 at 07:05, 1 year 2 months ago Le riliprubart obtient le statut de médicament orphelin aux États-Unis FDA Transplantation Rénale Médicament Orphelin Immunologie Riliprubart
Published on 09/19/2026 at 00:55, 1 day 18 hours ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 22:00, 1 day 21 hours ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 1 day 23 hours ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 2 days 5 hours ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/20/2026 at 15:10, 4 hours 24 minutes ago MSITEK Participates in New York Fashion Week Retail Innovation Lab
Published on 09/20/2026 at 09:05, 10 hours 29 minutes ago Huawei Digital Power Showcases Multi-Scenario Solutions Featuring Grid Forming and AI at IDEE 2026
Published on 09/20/2026 at 06:30, 13 hours 4 minutes ago Huawei Grid-Interactive AIDC Solution: Shaping the New Paradigm of AI Infrastructure
Published on 09/20/2026 at 04:35, 14 hours 59 minutes ago How to Achieve Sustainable Power Without Changing Your Existing Backup System
Published on 09/19/2026 at 16:40, 1 day 2 hours ago 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens
Published on 09/18/2026 at 18:34, 2 days 1 hour ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 2 days 1 hour ago Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Published on 09/18/2026 at 17:45, 2 days 1 hour ago Communiqué de presse_Carrefour Bond_Septembre 2026